[Skip to Content]
[Skip to Content Landing]

Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic

Educational Objective
To understand how to prioritize cancer care during a pandemic and in a low-resources settings
1 Credit CME

Importance  The coronavirus disease 2019 (COVID-19) pandemic has forced oncology clinicians and administrators in the United States to set priorities for cancer care owing to resource constraints. As oncology practices adapt to a contracted health care system, expertise gained from partnerships in low-resource settings can be used for guidance. This article provides a primer on priority setting in oncology and ethical guidance based on lessons learned from experience with cancer care priority setting in low-resource settings.

Observations  Lessons learned from real-world experiences are myriad. First, in the setting of limited resources, a utilitarian approach to maximizing survival benefit should guide decision-making. Second, conflicting principles will often arise among stakeholders and decision makers. Third, fair decision-making procedures should be established to ensure moral legitimacy and accountability. Fourth, proactive safeguards must be implemented to protect vulnerable individuals, or disparities in cancer treatment and outcomes will only widen further. Fifth, communication with patients and families about priority setting decisions should be intentional and standardized. Sixth, moral distress among clinicians must be addressed to avoid burnout during a time when resilience is critical.

Conclusions and Relevance  Although the need to triage cancer care may be new to those who underwent training and now practice oncology in high-resource settings, it is familiar for those who practice in low- and middle-income countries. Oncologists in the United States facing unprecedented decisions about prioritization can draw on ethical frameworks and lessons learned from real-world cancer care priority setting in resource-constrained environments.

Sign in to take quiz and track your certificates

Buy This Activity
Our websites may be periodically unavailable between 12:00am CT March 25, 2023 and 4:00pm CT March 26, 2023 for regularly scheduled maintenance.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: May 7, 2020.

Published Online: August 6, 2020. doi:10.1001/jamaoncol.2020.2976

Correction: This article was corrected on September 10, 2010, for a misspelled word in the title.

Corresponding Author: Rebecca J. DeBoer, MD, MA, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 505 Parnassus Ave, M1286, San Francisco, CA 94143-1270 (rebecca.deboer@ucsf.edu).

Author Contributions: Dr DeBoer had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: DeBoer, Shulman, Van Loon.

Acquisition, analysis, or interpretation of data: DeBoer, Fadelu.

Drafting of the manuscript: DeBoer, Van Loon.

Critical revision of the manuscript for important intellectual content: All authors.

Supervision: Shulman, Van Loon.

Conflict of Interest Disclosures: None reported.

Funding/Support: The research referenced in this article is supported by a “Making a Difference in Real-World Bioethics Dilemmas” grant from the Greenwall Foundation. Dr DeBoer was supported by the National Cancer Institute, the Fogarty International Center under Award D43TW009343, the Global Cancer Program at UCSF Helen Diller Family Comprehensive Cancer Center, and the University of California Global Health Institute (UCGHI).

Role of the Funder/Sponsor: The funding sources were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.

Emanuel  EJ , Persad  G , Upshur  R ,  et al.  Fair allocation of scarce medical resources in the time of COVID-19.   N Engl J Med. 2020;382(21):2049-2055. doi:10.1056/NEJMsb2005114PubMedGoogle Scholar
White  DB , Lo  B .  A framework for rationing ventilators and critical care beds during the COVID-19 pandemic.   JAMA. Published online March 27, 2020. doi:10.1001/jama.2020.5046 PubMedGoogle Scholar
Hanna  TP , Evans  GA , Booth  CM .  Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.   Nat Rev Clin Oncol. 2020;17(5):268-270. doi:10.1038/s41571-020-0362-6 PubMedGoogle Scholar
Schrag  D , Hershman  DL , Basch  E .  Oncology practice during the COVID-19 pandemic.   JAMA. Published online April 13, 2020. doi:10.1001/jama.2020.6236PubMedGoogle Scholar
van de Haar  J , Hoes  LR , Coles  CE ,  et al.  Caring for patients with cancer in the COVID-19 era.   Nat Med. 2020;26(5):665-671. doi:10.1038/s41591-020-0874-8PubMedGoogle Scholar
National Comprehensive Cancer Network. Coronavirus disease 2019 (COVID-19) resources for the cancer care community. Accessed May 1, 2020. https://www.nccn.org/covid-19/default.aspx
Yu  J , Ouyang  W , Chua  MLK , Xie  C .  SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China.   JAMA Oncol. 2020. Published online March 25, 2020. doi:10.1001/jamaoncol.2020.0980 PubMedGoogle Scholar
Liang  W , Guan  W , Chen  R ,  et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.   Lancet Oncol. 2020;21(3):335-337. doi:10.1016/S1470-2045(20)30096-6 PubMedGoogle Scholar
Marron  JM , Joffe  S , Jagsi  R , Spence  RA , Hlubocky  FJ .  Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic.   J Clin Oncol. 2020;38(19):2201-2205. Published online April 28, 2020. doi:10.1200/JCO.20.00960PubMedGoogle Scholar
Emanuel  E , Schmidt  H , Steinmetz  A .  Rationing and Resource Allocation in Healthcare: Essential Readings. Oxford University Press; 2018.
Biddison  ELD , Gwon  HS , Schoch-Spana  M ,  et al.  Scarce resource allocation during disasters: a mixed-method community engagement study.   Chest. 2018;153(1):187-195. doi:10.1016/j.chest.2017.08.001 PubMedGoogle Scholar
Schnipper  LE , Davidson  NE , Wollins  DS ,  et al; American Society of Clinical Oncology.  American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options.   J Clin Oncol. 2015;33(23):2563-2577. doi:10.1200/JCO.2015.61.6706 PubMedGoogle Scholar
Schnipper  LE , Davidson  NE , Wollins  DS ,  et al.  Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received.   J Clin Oncol. 2016;34(24):2925-2934. doi:10.1200/JCO.2016.68.2518 PubMedGoogle Scholar
Cherny  NI , Sullivan  R , Dafni  U ,  et al.  A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).   Ann Oncol. 2015;26(8):1547-1573. doi:10.1093/annonc/mdv249 PubMedGoogle Scholar
Cherny  NI , Dafni  U , Bogaerts  J ,  et al.  ESMO-Magnitude of Clinical Benefit Scale version 1.1.   Ann Oncol. 2017;28(10):2340-2366. doi:10.1093/annonc/mdx310 PubMedGoogle Scholar
Aggarwal  A , Ginsburg  O , Fojo  T .  Cancer economics, policy and politics: what informs the debate? perspectives from the EU, Canada and US.   J Cancer Policy. 2014;2(1):1-11. doi:10.1016/j.jcpo.2014.02.002 Google Scholar
Morgan  SG , McMahon  M , Mitton  C ,  et al.  Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom.   Health Aff (Millwood). 2006;25(2):337-347. doi:10.1377/hlthaff.25.2.337 PubMedGoogle Scholar
Lim  KSH , Vinod  SK , Bull  C , O’Brien  P , Kenny  L .  Prioritization of radiotherapy in Australia and New Zealand.   Australas Radiol. 2005;49(6):485-488. doi:10.1111/j.1440-1673.2005.01391.x PubMedGoogle Scholar
Jagsi  R , DeLaney  TF , Donelan  K , Tarbell  NJ .  Real-time rationing of scarce resources: the Northeast Proton Therapy Center experience.   J Clin Oncol. 2004;22(11):2246-2250. doi:10.1200/JCO.2004.10.083 PubMedGoogle Scholar
Jagsi  R , Spence  R , Rathmell  WK ,  et al.  Ethical considerations for the clinical oncologist in an era of oncology drug shortages.   Oncologist. 2014;19(2):186-192. doi:10.1634/theoncologist.2013-0301 PubMedGoogle Scholar
Hantel  A .  A protocol and ethical framework for the distribution of rationed chemotherapy.   J Clin Ethics. 2014;25(2):102-115.PubMedGoogle Scholar
Unguru  Y , Fernandez  CV , Bernhardt  B ,  et al.  An ethical framework for allocating scarce life-saving chemotherapy and supportive care drugs for childhood cancer.   J Natl Cancer Inst. 2016;108(6):djv392. doi:10.1093/jnci/djv392 PubMedGoogle Scholar
Hantel  A , Abel  GA , Siegler  M .  Practical allocation system for the distribution of specialised care during cellular therapy access scarcity.   J Med Ethics. 2019;45(8):532-537. doi:10.1136/medethics-2018-105339 PubMedGoogle Scholar
Binagwaho  A , Farmer  PE , Nsanzimana  S ,  et al.  Rwanda 20 years on: investing in life.   Lancet. 2014;384(9940):371-375. doi:10.1016/S0140-6736(14)60574-2 PubMedGoogle Scholar
Stulac  S , Binagwaho  A , Tapela  NM ,  et al.  Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience.   Lancet Oncol. 2015;16(8):e405-e413. doi:10.1016/S1470-2045(15)00161-8 PubMedGoogle Scholar
Ocean Road Cancer Institute. Historical background. Accessed September 5, 2017. https://www.orci.or.tz/historical-background/
International Monetary Fund, African Department.  Regional Economic Outlook: Sub-Saharan Africa: Navigating Uncertainty. International Monetary Fund; 2020.
Shulman  LN , Wagner  CM , Barr  R ,  et al.  Proposing essential medicines to treat cancer: methodologies, processes, and outcomes.   J Clin Oncol. 2016;34(1):69-75. doi:10.1200/JCO.2015.61.8736 PubMedGoogle Scholar
Anderson  BO , Shyyan  R , Eniu  A ,  et al.  Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.   Breast J. 2006;12(suppl 1):S3-S15. doi:10.1111/j.1075-122X.2006.00199.x PubMedGoogle Scholar
Chuang  LT , Temin  S , Camacho  R ,  et al.  Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline.   J Glob Oncol. 2016;2(5):311-340. doi:10.1200/JGO.2016.003954 PubMedGoogle Scholar
Carlson  RW , Scavone  JL , Koh  W-J ,  et al.  NCCN framework for resource stratification: a framework for providing and improving global quality oncology care.   J Natl Compr Canc Netw. 2016;14(8):961-969. doi:10.6004/jnccn.2016.0103 PubMedGoogle Scholar
Porter  ME .  What is value in health care?   N Engl J Med. 2010;363(26):2477-2481. doi:10.1056/NEJMp1011024 PubMedGoogle Scholar
Shyirambere  C , DeBoer  RJ , Bigirimana  JB ,  et al. Development of radiotherapy prioritization guidelines at Butaro Hospital in Rwanda. Paper presented at: African Organization for Research and Training in Cancer (AORTIC); November 2019; Maputo, Mozambique.
DeBoer  RJ , Nguyen  C , Shyirambere  C ,  et al. Experience and views of providers and program leaders engaged in patient prioritization for radiotherapy in Rwanda. Paper presented at: African Organization for Research and Training in Cancer (AORTIC); November 2019; Maputo, Mozambique.
Persad  G , Wertheimer  A , Emanuel  EJ .  Principles for allocation of scarce medical interventions.   Lancet. 2009;373(9661):423-431. doi:10.1016/S0140-6736(09)60137-9 PubMedGoogle Scholar
Miller  FG . Why I support age-related rationing of ventilators for COVID-19 patients. The Hastings Center. Published April 9, 2020. Accessed May 2, 2020. https://www.thehastingscenter.org/why-i-support-age-related-rationing-of-ventilators-for-covid-19-patients/
Aronson  L . “Covid-19 kills only old people.” only? New York Times. Published March 22, 2020. Accessed May 2, 2020. https://www.nytimes.com/2020/03/22/opinion/coronavirus-elderly.html
Daniels  N .  Decisions about access to health care and accountability for reasonableness.   J Urban Health. 1999;76(2):176-191. doi:10.1007/BF02344674 PubMedGoogle Scholar
Carrera  PM , Kantarjian  HM , Blinder  VS .  The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment.   CA Cancer J Clin. 2018;68(2):153-165. doi:10.3322/caac.21443 PubMedGoogle Scholar
Bibbins-Domingo  K .  This time must be different: disparities during the COVID-19 pandemic.   Ann Intern Med. Published online April 28, 2020. doi:10.7326/M20-2247PubMedGoogle Scholar
Benfer  EA , Wiley  LF . Health justice strategies to combat COVID-19: protecting vulnerable communities during a pandemic. Health Affairs. Published March 19, 2020. Accessed March 28, 2020. https://www.healthaffairs.org/do/10.1377/hblog20200319.757883/full/
American Society of Clinical Oncology. COVID-19 provider & practice information. Published March 18, 2020. Accessed March 23, 2020. https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19
Nouri  S , Khoong  EC , Lyles  CR , Karliner  L . Addressing equity in telemedicine for chronic disease management during the COVID-19 pandemic. NEJM Catalyst. Published May 4, 2020:13. Accessed June 25, 2020. https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0123
Bernacki  RE , Block  SD ; American College of Physicians High Value Care Task Force.  Communication about serious illness care goals: a review and synthesis of best practices.   JAMA Intern Med. 2014;174(12):1994-2003. doi:10.1001/jamainternmed.2014.5271 PubMedGoogle Scholar
Mack  JW , Cronin  A , Keating  NL ,  et al.  Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.   J Clin Oncol. 2012;30(35):4387-4395. doi:10.1200/JCO.2012.43.6055 PubMedGoogle Scholar
VitalTalk. COVID ready communication playbook. Accessed March 26, 2020. https://www.vitaltalk.org/guides/covid-19-communication-skills/
Jameton  A .  Nursing Practice: The Ethical Issues. Prentice-Hall; 1984.
Harrison  KL , Dzeng  E , Ritchie  CS ,  et al.  Addressing palliative care clinician burnout in organizations: a workforce necessity, an ethical imperative.   J Pain Symptom Manage. 2017;53(6):1091-1096. doi:10.1016/j.jpainsymman.2017.01.007 PubMedGoogle Scholar
Maruthappu  M , Watkins  J , Noor  AM ,  et al.  Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis.   Lancet. 2016;388(10045):684-695. doi:10.1016/S0140-6736(16)00577-8 PubMedGoogle Scholar
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience

Lookup An Activity


My Saved Searches

You currently have no searches saved.


My Saved Courses

You currently have no courses saved.